Status:
ENROLLING_BY_INVITATION
Evaluation of the Impact of Reduced Immunosuppression
Lead Sponsor:
Methodist Health System
Conditions:
Graft Vs Host Disease
Eligibility:
All Genders
18+ years
Brief Summary
Graft-versus-host disease (GVHD) is a life-threatening complication of transplantation. It occurs when the donor graft contains immunologically competent T-cells that recognize the recipient as foreig...
Detailed Description
GVHD is commonly observed in allogeneic hematopoietic stem cell transplantation recipients but can also occur in recipients of solid organ transplantation , with the first case of GVHD in a SOT recipi...
Eligibility Criteria
Inclusion
- ≥ 18 years
- Received OLT or CKLT during study period
Exclusion
- Recipients requiring re-transplant within one month post-transplant
- Recipients who died of a cause other than GVHD within one month post-transplant
Key Trial Info
Start Date :
October 19 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 19 2024
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05238155
Start Date
October 19 2021
End Date
October 19 2024
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203